PortfoliosLab logo

Clearside Biomedical, Inc. (CLSD)

Equity · Currency in USD · Last updated May 21, 2022

Company Info

Trading Data

  • Previous Close$1.38
  • Year Range$1.35 - $7.20
  • EMA (50)$1.79
  • EMA (200)$2.96
  • Average Volume$1.11M
  • Market Capitalization$86.62M

CLSDShare Price Chart


Chart placeholderClick Calculate to get results

CLSDPerformance

The chart shows the growth of $10,000 invested in Clearside Biomedical, Inc. on Jun 3, 2016 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,903 for a total return of roughly -80.97%. All prices are adjusted for splits and dividends.


CLSD (Clearside Biomedical, Inc.)
Benchmark (^GSPC)

CLSDReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-29.59%-12.57%
YTD-49.82%-18.14%
6M-69.27%-17.07%
1Y-43.90%-5.21%
5Y-29.69%10.37%
10Y-24.28%10.90%

CLSDMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

CLSDSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Clearside Biomedical, Inc. Sharpe ratio is -0.45. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


CLSD (Clearside Biomedical, Inc.)
Benchmark (^GSPC)

CLSDDividend History


Clearside Biomedical, Inc. doesn't pay dividends

CLSDDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


CLSD (Clearside Biomedical, Inc.)
Benchmark (^GSPC)

CLSDWorst Drawdowns

The table below shows the maximum drawdowns of the Clearside Biomedical, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Clearside Biomedical, Inc. is 97.63%, recorded on Sep 3, 2019. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.63%Oct 12, 2016727Sep 3, 2019
-17.17%Jun 3, 201646Aug 8, 201611Aug 23, 201657
-5.93%Sep 29, 20161Sep 29, 20162Oct 3, 20163
-5.91%Aug 24, 20163Aug 26, 20162Aug 30, 20165
-5.71%Sep 12, 20161Sep 12, 20165Sep 19, 20166
-4.1%Oct 4, 20161Oct 4, 20161Oct 5, 20162
-1.45%Sep 8, 20161Sep 8, 20161Sep 9, 20162
-1.09%Sep 22, 20161Sep 22, 20161Sep 23, 20162
-1.07%Aug 31, 20161Aug 31, 20161Sep 1, 20162
-0.67%Sep 6, 20161Sep 6, 20161Sep 7, 20162

CLSDVolatility Chart

Current Clearside Biomedical, Inc. volatility is 91.28%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


CLSD (Clearside Biomedical, Inc.)
Benchmark (^GSPC)

Portfolios with Clearside Biomedical, Inc.


Loading data...

More Tools for Clearside Biomedical, Inc.